Next Article in Journal
Estimated Costs of the Ipilimumab–Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma
Next Article in Special Issue
Feasibility of Using Wearables for Home Monitoring during Radiotherapy for Head and Neck Cancer—Results from the OncoWatch 1.0 Study
Previous Article in Journal
Quality of Life in Cutaneous T-cell Lymphoma Patients Receiving Mogamulizumab: Important Factors to Consider
Previous Article in Special Issue
The Normal, the Radiosensitive, and the Ataxic in the Era of Precision Radiotherapy: A Narrative Review
 
 
Article

Article Versions Notes

Action Date Notes Link
article xml file uploaded 21 December 2022 12:03 CET Original file -
article xml uploaded. 21 December 2022 12:03 CET Update -
article pdf uploaded. 21 December 2022 12:03 CET Version of Record https://www.mdpi.com/2072-6694/15/1/33/pdf-vor
article supplementary file uploaded. 21 December 2022 12:03 CET - https://www.mdpi.com/2072-6694/15/1/33#supplementary
article html file updated 21 December 2022 12:04 CET Original file -
article pdf uploaded. 31 January 2023 11:44 CET Updated version of record https://www.mdpi.com/2072-6694/15/1/33/pdf
article xml uploaded. 31 January 2023 11:44 CET Update -
article xml uploaded. 31 January 2023 11:44 CET Update https://www.mdpi.com/2072-6694/15/1/33/xml
article html file updated 31 January 2023 11:45 CET Update -
article html file updated 1 March 2023 05:19 CET Update -
article html file updated 4 March 2023 23:20 CET Update -
article html file updated 15 May 2023 14:11 CEST Update https://www.mdpi.com/2072-6694/15/1/33/html
Back to TopTop